Jurren van Opstal

6PUBLICATIONS
48CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Electrical circuits and systemsCircuits and systemsElectrical machines and drivesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 03, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.

Louise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani

|Nov 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.

Reinoud E Knops, Jolien A de Veld, Abdul Ghani

|Aug 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial.

Reinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy

|Oct 22, 2020
Drug-induced 'Torsade de Pointes' in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report.

Edimir Semedo, Gijs F Kapel, Jurren van Opstal

Pageof 1